Several groups are vying to be the first to transplant organs from genetically modified pigs into people as part of a clinical trial, New Scientist reported.
One of the contenders is a team in China that last year was the first to complete a human trial of CRISPR genome-edited pig skin grafts.
Read the full report: New Scientist
READ MORE:
Singapore Biomedical Firms Raise Record $600m – Straits Times
Chinese mRNA Jab Weaker Against Omicron, Trial Shows
US Bans China Firms Accused Of Aiding Abuses, ‘Mind Control’